Baricitinib is a selective and reversible Janus kinase (JAK) inhibitor that functions by blocking the JAK1 and JAK2 signaling pathways to reduce pro-inflammatory responses. Approved as a disease-modifying… Read more

![Chemical structure of (4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187595-90-9-4-1-3-Cyanomethyl-1-ethylsulfonylazetidin-3-yl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-ylmethyl-Pivalate.png&w=3840&q=75)
![Chemical structure of (4-(1-(3-(Cyanomethyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2102104-38-9-4-1-3-Cyanomethylazetidin-3-yl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-ylmethyl-Pivalate.png&w=3840&q=75)




![Chemical structure of 2,2'-(1H,1'H-[4,4'-Bipyrazole]-1,1'-diylbis(1-(ethylsulfonyl)azetidine-3,3-diyl))diacetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F22-1H1H-44-Bipyrazole-11-diylbis1-ethylsulfonylazetidine-33-diyldiacetonitrile.png&w=3840&q=75)

![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(4-oxo-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-5-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-1-Ethylsulfonyl-3-4-4-oxo-14-dihydro-2H-pyrimido45-d13oxazin-5-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(5-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-1-Ethylsulfonyl-3-4-5-hydroxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187594-13-3-2-1-Ethylsulfonyl-3-4-7-2-trimethylsilylethoxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187595-89-6-2-1-Ethylsulfonyl-3-4-7-hydroxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-1-Ethylsulfonyl-3-4-7-nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetamide.png&w=3840&q=75)
![Chemical structure of 2-(1-(Ethylsulfonyl)-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-1-Ethylsulfonyl-3-4-7-nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile.png&w=3840&q=75)

![Chemical structure of 2-(3-(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2402776-84-3-2-3-4-1-3-Cyanomethyl-1-ethylsulfonylazetidin-3-yl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-yl-1-ethylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)

![Chemical structure of 2-(3-(4-(7-Nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(propylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-3-4-7-Nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-propylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-[4,7'-Bipyrrolo[2,3-d]pyrimidin]-4'-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2910813-45-3-2-3-4-7H-47-Bipyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-((ethyl-d5)sulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1564241-79-7-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethyl-d5sulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(butylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187594-35-9-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-butylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2271228-51-2-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethylsulfonylazetidin-3-ylacetamide.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2271228-52-3-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethylsulfonylazetidin-3-ylacetic-acid.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(methylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187594-29-1-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-methylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(propylsulfonyl)azetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1187594-34-8-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-propylsulfonylazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-nitrosoazetidin-3-yl)acetonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-nitrosoazetidin-3-ylacetonitrile.png&w=3840&q=75)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1627504-43-1-2-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylazetidin-3-ylacetonitrile-Dihydrochloride.png&w=3840&q=75)

![Chemical structure of 2-Chloro-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F335654-06-3-2-Chloro-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)
![Chemical structure of 3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidine-3-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethylsulfonylazetidine-3-carboxamide.png&w=3840&q=75)



![Chemical structure of 4-(1H-Pyrazol-4-yl)-7-(((2-(trimethylsilyl)ethoxy)methoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-1H-Pyrazol-4-yl-7-2-trimethylsilylethoxymethoxymethyl-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)
![Chemical structure of 4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F952518-97-7-4-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)


![Chemical structure of 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F941685-26-3-4-Chloro-7-2-trimethylsilylethoxymethyl-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)
![Chemical structure of 4-Chloro-7-nitroso-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-Chloro-7-nitroso-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)




![Chemical structure of Methyl 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2402776-80-9-Methyl-2-3-4-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-1-ethylsulfonylazetidin-3-ylacetate.png&w=3840&q=75)
![Chemical structure of Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1095822-17-5-Methyl-7H-pyrrolo23-dpyrimidine-4-carboxylate.png&w=3840&q=75)
![Chemical structure of N-((3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-5-oxotetrahydrofuran-3-yl)methyl)ethanesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2910813-43-1-N-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-5-oxotetrahydrofuran-3-ylmethylethanesulfonamide.png&w=3840&q=75)



Baricitinib is a selective and reversible Janus kinase (JAK) inhibitor that functions by blocking the JAK1 and JAK2 signaling pathways to reduce pro-inflammatory responses. Approved as a disease-modifying antirheumatic drug, it is prescribed for the treatment of moderate to severe active rheumatoid arthritis, alopecia areata, and certain inflammatory conditions such as COVID-19. To support stringent pharmaceutical analysis, this category provides a comprehensive range of reference standards, including the active pharmaceutical ingredient, synthetic intermediates, process-related impurities, degradation products, and stable isotope labelled compounds. These high-quality materials are essential for laboratories performing impurity profiling, method validation, and quality control. By utilizing these precisely characterized reference standards, researchers can ensure regulatory compliance, achieve accurate identification and quantification of impurities, and maintain the reliability of stability testing throughout the drug’s lifecycle.